This afternoon we watched CVS Health drop -2.6% to a price of $69.5 per share. The large-cap Pharmaceutical Retail company is now trading -23.24% below its average target price of $90.54. Analysts have set target prices ranging from $76.0 to $110.0 per share for CVS Health, and have given the stock an average rating of buy.
CVS Health's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.2%. The stock's short ratio is 1.61. The company's insiders own 0.18% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 79.9%. In conclusion, we believe there is mixed market sentiment regarding CVS Health.
Institutions Invested in CVS Health
|2023-06-30||Vanguard Group Inc||9%||116,676,882||$8,109,054,871|
|2023-06-30||State Street Corporation||4%||55,877,387||$3,883,483,938|
|2023-06-30||Capital World Investors||2%||30,490,802||$2,119,113,763|
|2023-06-30||Geode Capital Management, LLC||2%||23,325,287||$1,621,109,759|
|2023-06-30||Bank of America Corporation||1%||16,551,119||$1,150,304,412|
|2023-06-30||Dodge & Cox Inc||1%||16,024,422||$1,113,698,918|